The Epstein-Barr Virus (EBV) Evaluation is a blood test that includes four EBV-specific antibody measurements used to assess current, recent, or past EBV infection. By evaluating different antibody types, this panel helps determine the stage of infection and whether symptoms may be related to acute infection, prior exposure, or possible viral reactivation.
This panel is commonly ordered when symptoms such as prolonged fatigue, fever, sore throat, swollen lymph nodes, or unexplained illness are present. Results are interpreted together to provide a clearer picture of EBV immune status.
The panel includes 4 tests:
EBV VCA IgG (EBVCG): Indicates past EBV exposure
EBV Nuclear Antigen IgG (EBNAG): Confirms prior infection and long-term immunity
EBV Early Antigen IgG (EDEAG): May be associated with recent infection or reactivation
EBV VCA IgM (EBVCM): Suggests recent or acute EBV infection
The Epstein-Barr Virus (EBV) Evaluation is a blood test that includes four EBV-specific antibody measurements used to assess current, recent, or past EBV infection. By evaluating different antibody types, this panel helps determine the stage of infection and whether symptoms may be related to acute infection, prior exposure, or possible viral reactivation.
This panel is commonly ordered when symptoms such as prolonged fatigue, fever, sore throat, swollen lymph nodes, or unexplained illness are present. Results are interpreted together to provide a clearer picture of EBV immune status.
The panel includes 4 tests:
EBV VCA IgG (EBVCG): Indicates past EBV exposure
EBV Nuclear Antigen IgG (EBNAG): Confirms prior infection and long-term immunity
EBV Early Antigen IgG (EDEAG): May be associated with recent infection or reactivation
EBV VCA IgM (EBVCM): Suggests recent or acute EBV infection
